Skip to content

13F-HR filed by New Leaf Venture Partners, L.L.C.

New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 10 holding rows worth $82,237,627.

Accession
0000950123-24-008255
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 10 entries on the cover page, a total value of $82,237,627 stated on the cover page (in dollars after the unit check, H1), rows summing to $82,237,627 with VALUE read as dollars as filed, 13F file number 028-16681. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARVINAS INC04335A105COM1,289,521$34,327,049dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM1,553,661$27,981,435dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock141,000$6,315,390dollars as filed
RALLYBIO CORP75120L100COM3,301,603$4,424,148dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM150,706$3,244,700dollars as filed
COGENT BIOSCIENCES INC19240Q201COM250,765$2,113,949dollars as filed
PASSAGE BIO INC702712100COM2,497,922$1,983,850dollars as filed
ALECTOR INC014442107COMMON STOCK339,569$1,541,643dollars as filed
X4 Pharmaceuticals, Inc.98420X103COM335,000$194,300dollars as filed
ITERUM THERAPEUTICS PLCG6333L200COM97,086$111,163dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-008255this filing2024-08-14acceptance time not in the bulk data set